Recap: Ovid Therapeutics Q4 Earnings

Ovid Therapeutics OVID reported its Q4 earnings results on Friday, March 8, 2024 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Ovid Therapeutics missed estimated earnings by -340.0%, reporting an EPS of $-0.22 versus an estimate of $-0.05.

Revenue was up $95 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 1.0% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Ovid Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.